Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, NTNU, Postboks 8905, 7491, Trondheim, Norway.
Unicare Helsefort Rehabilitation Centre, Rissa, Norway.
J Occup Rehabil. 2021 Dec;31(4):721-728. doi: 10.1007/s10926-021-09969-4. Epub 2021 Mar 25.
Purpose There is a lack of results on long-term effects of return to work interventions. We previously reported that an inpatient multimodal occupational rehabilitation program (I-MORE) was more effective in reducing sickness absence and facilitating return to work (RTW) at 12 months follow-up compared to an outpatient program that consisted mainly of Acceptance and Commitment Therapy (O-ACT). We now report the 2-year outcome data. Methods A randomized clinical trial with parallel groups. Participants were 18-60 years old, sick listed with musculoskeletal, common mental or general/unspecified disorders. I-MORE lasted 3.5 weeks and consisted of ACT, physical training and work-related problem solving. O-ACT consisted mainly of 6 weekly sessions (2.5 h. each) of ACT in groups. Outcomes were cumulated number of days on medical benefits and time until sustainable RTW (1 month without medical benefits) during 2-years of follow-up, measured by registry data. Results For the 166 randomized participants, the median number of days on medical benefits was 159 (IQR 59-342) for I-MORE vs 249 days (IQR 103-379; Mann-Whitney U test, p = 0.07), for O-ACT. At 2 years, 40% in I-MORE received long-term benefits (work assessment allowance) vs 51% in O-ACT. The crude hazard ratio (HR) for sustainable RTW was 1.59 (95% CI 1.04-2.42, p = 0.03) and the adjusted HR 1.77 (95% CI 1.14-2.75, p = 0.01), in favor of I-MORE. Conclusions The 2-year outcomes show that I-MORE had long-term positive effects on increasing work participation for individuals sick listed with musculoskeletal and mental disorders. Further follow-up and economic evaluations should be performed.
关于重返工作岗位干预措施的长期效果,目前仍缺乏相关研究结果。我们之前的研究报告表明,与主要采用接受与承诺疗法(ACT)的门诊方案(O-ACT)相比,住院多模式职业康复方案(I-MORE)在 12 个月随访时,更能有效减少病假时间并促进重返工作岗位(RTW)。本研究报告了为期 2 年的研究结果。
这是一项采用平行分组的随机临床试验。参与者年龄在 18-60 岁之间,患有肌肉骨骼、常见精神或一般/未特指的疾病而请病假。I-MORE 持续 3.5 周,包含 ACT、体能训练和与工作相关的问题解决。O-ACT 主要由 6 次每周的小组 ACT 课程(每次 2.5 小时)组成。通过登记数据,在 2 年的随访期间,测量累积的病假天数和可持续 RTW(1 个月无需病假)的时间,作为结局指标。
对于 166 名随机参与者,I-MORE 的平均病假天数为 159 天(IQR 59-342),而 O-ACT 为 249 天(IQR 103-379;Mann-Whitney U 检验,p=0.07)。在 2 年时,I-MORE 中有 40%的参与者获得了长期受益(工作评估津贴),而 O-ACT 中有 51%的参与者获得了长期受益。可持续 RTW 的粗危险比(HR)为 1.59(95%CI 1.04-2.42,p=0.03),调整后的 HR 为 1.77(95%CI 1.14-2.75,p=0.01),有利于 I-MORE。
2 年的研究结果表明,I-MORE 对促进肌肉骨骼和精神疾病患者的工作参与具有长期的积极影响。应该进行进一步的随访和经济评估。